tiprankstipranks
MyHealthChecked PLC (GB:MHC)
LSE:MHC

MyHealthChecked PLC (MHC) Income Statement

2 Followers

MyHealthChecked PLC Income Statement

Last quarter (Q4 2022), MyHealthChecked PLC's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, MyHealthChecked PLC's net income was £―. See MyHealthChecked PLC’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
-£ 22.31M£ 16.38M£ 49.48K£ 31.97K£ 4.84K
Cost of Revenue
-£ 17.67M£ 11.25M£ 689.78K£ 492.14K£ 540.72K
Gross Profit
-£ 4.65M£ 5.13M£ -640.30K£ -460.17K£ -535.88K
Operating Expense
-£ 3.13M£ 2.67M£ 2.32M£ 2.01M£ 2.31M
Operating Income
-£ 1.51M£ 2.46M£ -2.96M£ -2.47M£ -2.84M
Net Non Operating Interest Income Expense
-£ -2.00K£ 2.00K£ -4.56K£ -26.35K£ -23.91K
Other Income Expense
-£ -13.00K----
Pretax Income
-£ 1.52M£ 2.00M£ -3.76M£ -2.49M£ -2.87M
Tax Provision
---£ 0.00£ -344.88K£ -52.28K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-£ 1.52M£ 2.00M£ -3.76M£ -2.15M£ -2.81M
Basic EPS
---£ -0.01£ -0.01£ -0.02
Diluted EPS
---£ -0.01£ -0.01£ -0.02
Basic Average Shares
-£ 774.30B£ 47.39M£ 420.76M£ 240.78M£ 158.32M
Diluted Average Shares
-£ 778.22B£ 49.60M£ 420.76M£ 240.78M£ 158.32M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
---£ 50.50K£ 63.60K£ 72.52K
Total Expenses
-£ 20.80M£ -13.92M£ 3.01M£ 2.50M£ 2.85M
Net Income From Continuing And Discontinued Operation
-£ 1.52M£ 2.00M£ -3.76M£ -2.15M£ -2.81M
Normalized Income
-£ 2.22M£ 2.08M£ -2.96M£ -2.15M£ -2.81M
Interest Expense
---£ 4.56K£ 26.35K£ 23.91K
EBIT
-£ 1.52M£ 2.01M£ -3.76M£ -2.47M£ -2.84M
EBITDA
-£ 1.74M£ 2.01M£ -3.60M£ -2.20M£ -2.65M
Currency in GBP

MyHealthChecked PLC Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis